Swiss regulator approves blood safety system from Cerus

08/19/2009 | Reuters

Swissmedic granted approval to Cerus' Intercept blood system, which inactivates viruses, bacteria and other blood-borne pathogens in blood components used for transfusion. The company said the approval allows Intercept-treated platelets to be stored for a week.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA